Literature DB >> 8157762

Waldenström's macroglobulinaemia secreting a paraprotein with lupus anticoagulant activity: possible association with gastrointestinal tract disease and malabsorption.

R C Tait1, P K Oogarah, J B Houghton, S E Farrand, M R Haeney.   

Abstract

A 51 year old man with Waldenström's macroglobulinaemia presented with a malabsorptive syndrome related to extensive small bowel lymphangiectasia caused by immunoglobulin accumulation. The patient's plasma had strong lupus anticoagulant activity and the IgM lambda paraprotein displayed specificity for the negatively charged phospholipids phosphatidyl serine and phosphatidyl inositol, as well as the neutral phosphatidic acid. Despite treatment for the macroglobulinaemia the patient died and at necropsy was found to have myocardial ischaemia and segmental infarcts in the spleen and kidney. The coexistence of these relatively rare findings suggests a possible association between Waldenström's macroglobulinaemia with gastrointestinal manifestations and paraprotein specificity for phospholipid.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8157762      PMCID: PMC501404          DOI: 10.1136/jcp.46.7.678

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  8 in total

1.  INTESTINAL LOCALIZATION OF WALDENSTROM'S DISEASE.

Authors:  A CABRERA; S DELAPAVA; J W PICKREN
Journal:  Arch Intern Med       Date:  1964-09

2.  Study of three patients with monoclonal gammopathies and 'lupus-like' anticoagulants.

Authors:  V Bellotti; G Gamba; G Merlini; N Montani; E Bucciarelli; M Stoppini; E Ascari
Journal:  Br J Haematol       Date:  1989-10       Impact factor: 6.998

3.  Intestinal involvement in Waldenstrom's macroglobulinemia.

Authors:  M S Bedine; J H Yardley; H L Elliott; J G Banwell; T R Hendrix
Journal:  Gastroenterology       Date:  1973-08       Impact factor: 22.682

4.  Malabsorption syndrome with infiltration of the intestinal wall by extracellular monoclonal macroglobulin.

Authors:  W Pruzanski; R E Warren; J H Goldie; A Katz
Journal:  Am J Med       Date:  1973-06       Impact factor: 4.965

5.  A monoclonal IgM with antibodylike specificity for phospholipids in a patient with lymphoma.

Authors:  M R Cooper; H J Cohen; C C Huntley; B M Waite; L Spees; C L Spurr
Journal:  Blood       Date:  1974-04       Impact factor: 22.113

6.  Lupus anticoagulant: an analysis of the clinical and laboratory features of 219 cases.

Authors:  D A Gastineau; F J Kazmier; W L Nichols; E J Bowie
Journal:  Am J Hematol       Date:  1985-07       Impact factor: 10.047

7.  Macroglobulinaemia and intestinal lymphangiectasia: a rare association.

Authors:  M Harris; I E Burton; J H Scarffe
Journal:  J Clin Pathol       Date:  1983-01       Impact factor: 3.411

8.  Monoclonal immunoglobulin M lambda coagulation inhibitor with phospholipid specificity. Mechanism of a lupus anticoagulant.

Authors:  P Thiagarajan; S S Shapiro; L De Marco
Journal:  J Clin Invest       Date:  1980-09       Impact factor: 14.808

  8 in total
  1 in total

1.  "Primary" antiphospholipid syndrome evolving into Waldenstrom's macroglobulinaemia: a case report.

Authors:  R A Asherson; M C Davidge-Pitts; E Wypkema
Journal:  Clin Rheumatol       Date:  2006-03-18       Impact factor: 2.980

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.